Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Outstanding: 114,144,104 for July 5, 2023
Monthly 5th Report
https://webfiles.thecse.com/Cannabix_Monthly_Progress_Report_Form_7_July_5_2023.pdf?2qYWZ9noSGGmVgMX4rglOFAg6yG.bQQR
Explore Spin-Off of its Ifenprodil Phase 2 Chronic Cough Drug Development Program
https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Engages-Maxim-Group-to-Explore-Spin-Off-of-its-Ifenprodil-Phase-2-Chronic-Cough-Drug-Developmen?id=405608
Good Video - Here’s a $AGNPF & Jacky Smith News clip
https://www.globenewswire.com/en/news-release/2020/02/07/1981672/0/en/Algernon-Pharmaceuticals-Appoints-Professor-of-Respiratory-Medicine-Dr-Jacky-Smith-to-Its-Medical-and-Scientific-Advisory-Board.html
Form 62-103F3 - AlphaNorth Asset Management (the “Offeror”)
Detects THC in Breath after Edibles Consumption
https://www.sedar.com/GetFile.do?lang=EN&docClass=8&issuerNo=00034382&issuerType=03&projectNo=03550121&docId=5445927
FORM OF PROXY (“PROXY”)
https://webfiles.thecse.com/CTI_Proxy_FINAL.pdf?LaoHOoJ657CfCA9JtE9aRRYfa7Rncm.X
INFORMATION CIRCULAR & NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON JULY 28, 2023
https://webfiles.thecse.com/Cannabix_-_AGM_2023_Notice_of_Meeting_and_Information_Circular_final_June_13_2023.pdf?K13NtKCSl.Wn537unW37Dp0I2Kty5LaG
Cannabix’s MSBS Marijuana Breathalyzer Technology Detects THC in Breath after Edibles Consumption
https://www.otcmarkets.com/stock/BLOZF/news/story?e&id=2554879
Outstanding: 14,550,757 for June 5, 2023 Monthly Report
Monthly 5th Report
https://webfiles.thecse.com/5._Algernon_-_CSE_Form_7_-_May_2023.pdf?Ghag5daIWQXtzfM02z6tAHLE0LvW664R
Algernon Pharmaceuticals to Present Phase 2 Ifenprodil Cough Data at the 2023 American Cough Conference
https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-to-Present-Phase-2-Ifenprodil-Cough-Data-at-the-2023-American-Cough-Conference?id=403381
CEO Discusses Successful High Dose Completion in DMT Phase 1 Trial for Stroke and TBI
Outstanding: 114,144,104 for June 5, 2023
https://webfiles.thecse.com/Cannabix_Monthly_Progress_Report_Form_7_June_5_2023.pdf?4MeRBSGLSHZ0l_eiTuES7emTFOBSsR2T
Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Studies
https://www.otcmarkets.com/stock/AGNPF/news/Algernon-NeuroScience-Announces-Successful-Completion-of-Highest-Planned-Single-Dose-in-DMT-Phase-1-Trial-Accelerates-Pl?id=403236
Outstanding Shares 690,499,016 posted 06/01/2023
https://www.otcmarkets.com/stock/MEDH/security
Proactive Investors CEO Interview - Algernon Receives Notice of Allowance for Patent to Treat Chronic Kidney Disease in Japan
Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office for Repirinast and the Treatment of CKD
https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Receives-Notice-of-Allowance-from-the-Japanese-Patent-Office-for-Repirinast-and-the-Treatment-o?id=402759
Researchers Analyze THC in Breath of Cannabis Smokers
https://www.nist.gov/news-events/news/2023/05/researchers-analyze-thc-breath-cannabis-smokers
Update for $Medh SHs
Submitted additional documents last night to FiNRA. When name change is complete, we can regain access to OTCIQ and upload fins. Also, we need to complete form211 so we may upgraded from Expert Market and reinstated back to OTC
https://twitter.com/The1OnlyHans
Here’s one to ponder
Last Day of Grace Period: 05/15/2023
https://www.otcmarkets.com/stock/MEDH/quote
Will be this time next Week
Outstanding 14,550,757 posted 05/05/2023
https://webfiles.thecse.com/AGNnr050523.pdf?s1D15s.jSGWKuDMQOgJQhRjbY8FCgwF1
Filing that it’s Closed
https://webfiles.thecse.com/AGN_-_CSE_Letter_-_Rights_Offering.pdf?_JRPsqcI6pQi6nS3fuTZjpJvK2ENxAha
New types of cannabis businesses coming to Albuquerque
https://www.kob.com/new-mexico/new-types-of-cannabis-businesses-coming-to-albuquerque/
Outstanding: 9,666,988 as of April 30, 2023
Monthly 5th Report
https://webfiles.thecse.com/4._Algernon_-_CSE_Form_7_-_April_2023.pdf?yrwmiJUqOadbuiOPBeUElZyTXQW8vjHn
In that link to the Rights Closing of 4,753,369 it quoted this
At closing, the Company issued 4,753,369 units (the “Units”) at the subscription price of $0.25 per Unit for total gross proceeds of approximately $1,188,342
https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Announces-Closing-of-Rights-Offering?id=399577
Outstanding: 114,144,104 for May 5, 2023
https://webfiles.thecse.com/Cannabix_Monthly_Progress_Report_Form_7_May_5_2023.pdf?Oo.n5tU67I2nrQJidqA1HgRv6OSzPC4s
Roughly 75 a month or 2.5 a day
Cannabix Technologies Files Contact-Free Breath Patent Application and Updates on Development and Certification Plans
https://www.otcmarkets.com/stock/BLOZF/news/story?e&id=2516354
Pennsylvania - Law Attorney advice
https://gambonelaw.com/medical-marijuana-dui-and-your-pennsylvania-drivers-license/
After a couple Reverse’s which works out to 1 share from 200 then Forward 4 from 1
So real claim is 1 share from 50
Rights were right to give to holders of shares for .18 $AGNPF or .25 $AGN
I hope it shows 9.6 bought the Right for .18 $AGNPF or .25 $AGN
$2.5M CAD for the Company for $Cash on hand to pay Expenses
Plus those Buying $2.5M @ .18 $AGNPF or .25 $AGN are the shareholders already so the bottom is in
JMO — Expect it to look as a fall but it will be a fake and any wanting to Jump will be bought, has to be better than .18 $AGNPF or .25 $AGN for $2.5M CAD investment — No need to run it up if they can get Shareholders to Jump on keeping it low and Jumpers jump
Another Opinion — News will come but probably guided to sell the $10M USD Nasdaq shares of Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M
Under the Reg A+, AGN Neuro will be offering up to 37.5% of its common shares, with majority ownership residing with AGN Pharma.
Meaning if all the Rights get bought
19.3M Outstanding worth $20M USD
$1.03 $AGNPF
Remember the 1 from 50 Splits ?
Gain of .02 $AGNPF if & only if they sell 37.5% $10M Nasdaq Buyers and leave 62.5% for holders in $AGNPF & $AGN
Time for Shareholders to be rewarded some gain somewhere
Yeah I believe News will be quite to get Jumpers to jump and then when their ready for the $10M Nasdaq Investment — News will hit just before Buyers can Buy
JMO
Meaning this next Monthly 5th Report will show how many of the 9.65 million shares outstanding converted their Rights for a .18 $AGNPF or .25 $AGN cost for an additional shares
JMO - Outstanding Gonna Double
Email from CEO of Algernon Pharma - If your on their mailing list you got one today
Algernon Pharmaceuticals Reminds Shareholders of Previously Announced Rights Offering and Approaching Cut Off Date and Time
https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Reminds-Shareholders-of-Previously-Announced-Rights-Offering-and-Approaching-Cut-Off-Date-and-T?id=397294
Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news the company has received a Notice of Allowance for a patent around its work chronic kidney disease.